Targeting constitutively-activated STAT3 in hypoxic ovarian cancer, using a novel STAT3 inhibitor
Georgia A. McCann(The Ohio State University Wexner Medical Center), Karuppaiyah Selvendiran(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute)
Cited by 35
Related Papers
Hypoxia induces chemoresistance in ovarian cancer cells by activation of signal transducer and activator of transcription 3
|International Journal of Cancer|2009|124
High Glucose-Mediated STAT3 Activation in Endometrial Cancer Is Inhibited by Metformin: Therapeutic Implications for Endometrial Cancer
|PLoS ONE|2017|39
ISG15 mediates the function of extracellular vesicles in promoting ovarian cancer progression and metastasis
|Journal of Extracellular Biology|2024|11